MedTrace Logo

Prediction of Survival in Children With Cystic Fibrosis Using the Multiple-breath Washout

NCT04016194 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-07-11

No results posted yet for this study

Summary

Retrospective cohort study using routinely collected annual data on lung clearance index (LCI) in combination with clinical data to predict survival in patients with Cystic Fibrosis. The primary study endpoint is the association of LCI with the compound outcome survival or lung transplantation in patients with CF.

Conditions

Interventions

DIAGNOSTIC_TEST

Lung function testing

Multiple-breath washout (MBW) is a safe, easy and sensitive lung function test using inert gases such as Nitrogen (N2) to assess efficiency of ventilation distribution. The latter can be estimated by the lung clearance index (LCI), an established study end-point in patients with CF

Sponsors & Collaborators

  • Lindenhofspital

    collaborator UNKNOWN

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Florian Singer · Insel Gruppe AG, University Hospital Bern

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-01-01
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016194 on ClinicalTrials.gov